Cargando…
Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
PURPOSE: To evaluate the outcome of glaucoma drainage device (GDD) implantation with and without intravitreal bevacizumab (IVB) injection in treating neovascular glaucoma (NVG) at Cipto Mangunkusumo Hospital Jakarta, Indonesia. PATIENTS AND METHODS: This retrospective study involved 39 eyes with NVG...
Autores principales: | Noor, Nina Asrini, Mustafa, Syukri, Artini, Widya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557098/ https://www.ncbi.nlm.nih.gov/pubmed/28848323 http://dx.doi.org/10.2147/OPTH.S137470 |
Ejemplares similares
-
Combined Dexamethasone Intravitreal Implant and Glaucoma Drainage Device Placement for Uveitic Glaucoma
por: Nguyen, Tran, et al.
Publicado: (2020) -
Intravitreal Bevacizumab (Avastin) as an Adjuvant Treatment in Cases of Neovascular Glaucoma
por: Ghanem, Asaad A., et al.
Publicado: (2009) -
Challenging Management of Neovascular Glaucoma to Achieve the Best Visual Outcome
por: Putera, Ikhwanuliman, et al.
Publicado: (2020) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey, Hatem M, et al.
Publicado: (2011) -
Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)